Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6 Month, Prospective, Open-Label Multiple Center Extension Trial To Evaluate The Long Term Safety And Sustained Efficacy Of Fragmin In The Treatment Of Chronic Foot Ulcers In Diabetic Patients With Peripheral Arterial Occlusive Disease

NCT00765063 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00765063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00765063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6 Month, Prospective, Open-Label Multiple Center Extension Trial To Evaluate The Long Term Safety And Sustained Efficacy Of Fragmin In The Treatment Of Chronic Foot Ulcers In Diabetic Patients With Peripheral Arterial Occlusive Disease
Lead sponsor
Pfizer
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2008
Completion date
October 31, 2010
Enrollment
62 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer